CPC on Cervical Pathology

Similar documents
Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Cervical Cancer: 2018 FIGO Staging

Cervical cancer presentation

Coversheet for Network Site Specific Group Agreed Documentation

Cervical Cancer Early Detection, Diagnosis, and Staging

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Estimated New Cancers Cases 2003

Understanding Your Pap Test Results

Staging and Treatment Update for Gynecologic Malignancies

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

Cervical Conization. 1

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous

Jacqui Morgan March 6, 2019

Chapter 8 Adenocarcinoma

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive

Algorithms for management of Cervical cancer

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Vaginal intraepithelial neoplasia

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

What Causes Cervical Cancer? Symptoms of Cervical Cancer

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE.

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Management of Abnormal Cervical Cytology and Histology

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Gynecologic Oncology Overview Staging updates and Soap Box Issues

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Management that provides continuity of care for women

Uterus Malignancies /5/15

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Carcinoma of the Cervix Histopathology Reporting Guide

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

Understand Your Results

Dr. Homer Bloomfield Cancer Society of the Bahamas

NAACCR Webinar Series /7/17

What is endometrial cancer?

Computed tomography for evaluation of cervical carcinoma: Our experience in a tertiary care hospital.

What is Cervical Cancer?

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

of surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

ECC or Margins Positive?

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

The society for lower genital tract disorders since 1964.

Current staging of endometrial carcinoma with MR imaging

Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham

Janjira Petsuksiri, M.D

Uterine Malignancies. Collecting Cancer Data: Uterine Malignancies 10/7/2010. NAACCR Webinar Series 1. Questions. Fabulous Prizes!!!

In situ and Invasive Endocervical Carcinoma: Problems and Pitfalls in Diagnosis

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Managament of Abnormal Cervical Cytology and Histology

International Federation of Gynecology and Obstetrics

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

Your Colposcopy Visit

MANAGEMENT OF CERVICAL CANCER

The new FIGO classification in endometrial carcinoma

Sonographic Detection of Cervical Carcinoma With Metastases

Done by khozama jehad. Neoplasia of the cervix

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Colposcopy. Attila L Major, MD, PhD

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

Cervical Dysplasia and HPV

Chapter 10: Pap Test Results

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Endometrial Cancer. Incidence. Types 3/25/2019

CERVICAL CANCER: A GUIDE FOR PATIENTS

Vaginal Cancer Early Detection, Diagnosis, and Staging

Role and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

How invasive cervical cancer audit affects clinical practice

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester

Cervical Cancer. University of Massachusetts Medical School. Anne Garrison University of Massachusetts Medical School

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Guideline for the Management of Vulval Cancer

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

I have no financial interests in any product I will discuss today.

Becoming a colposcopist: Colposcope case studies

MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI

University of Kentucky. Markey Cancer Center

This protocol is intended to assist pathologists in providing

Cryotherapy has No Place in Colposcopy Practice

Transcription:

CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital

Cervical Smear: High Grade SIL (CIN III)

Cervical Smear: High Grade SIL & HPV Effect

Punch Biopsy: CIN III / Carcinoma-in-situ with? Early Invasion

Punch Biopsy: CIN III / Carcinoma-in-situ

Cone Biopsy: CIN III / Carcinoma-in-situ

Cone Biopsy: CIN III Extending to Endocervical Gland

Depth of Invasion = 3.6 mm Cone Biopsy: Microinvasive Squamous Cell Carcinoma

Histologic Diagnosis Microinvasive squamous cell carcinoma At 11 & 12 o clock (horizontal spread < 7 mm) Depth of invasion = 3.6 mm

Microinvasive Squamous Cell Carcinoma Synonym: Superficially invasive CA; CA with early stromal invasion. Corresponds to FIGO stage IA: CA with maximum depth of invasion = 5 mm & maximum horizontal spread = 7 mm. Capillary-lymphatic space invasion may or may not be present.

Microinvasive Squamous Cell Carcinoma 21% of all cervical squamous cell CA. Overall risk of lymph node metastasis about 1%: - Invasion up to 3 mm: < 1%. - Invasion of 3.1 5 mm: 4.3%. Refined definition: - 3 mm as cutoff point with no capillarylymphatic space invasion (Society of Gynecologic Oncology). - Tumor volume (< 420 mm 2 ).

Updated FIGO Staging of CA Cervix 0 CA-in-situ I CA strictly confined to cervix (extension to uterus corpus should be disregarded & lymphovascular permeation does not alter the stage). IA Preclinical invasive CA (microinvasive CA), i.e. diagnosed only by microscopy. - IA1 Stromal invasion 3 mm or less in depth & 7 mm or less in horizontal spread. - IA2 Stromal invasion > 3 mm & not more than 5 mm in depth, with horizontal spread of 7 mm or less. IB Clinically visible lesion confined to cervix or microscopic lesion greater than IA2.

Updated FIGO Staging of CA Cervix II Invasive CA that extends beyond uterus, but not reaching pelvic side wall or lower one-third of vagina. IIA Without parametrial invasion IIB With parametrial invasion III Invasive CA that extends to either lateral pelvic wall & / or lower third of vagina & / or hydronephrosis or nonfunctioning kidney due to tumor. IVA Invasive CA that invades mucosa of urinary bladder & / or rectum or extends beyond true pelvis. IVB Distant metastasis.

Technical & Practical Problems in Cervical Biopsies

Types of Cervical Biopsies Colposcopically-directed punch biopsy Endocervical curettage Cone biopsy LLETZ (large loop excision of the transformation zone) / LEEP (loop electrosurgical excision procedure)

Technical & Practical Problems in Cervical Biopsies: Punch Biopsy Sampling problems: - Entire transformation zone may not be visualized & will then not be accessible to biopsy. - Loss of fragile surface mucosa may lead to false-negative result. Interpretation problems: - Tangential sectioning may lead to overestimation of severity of changes or produce artifacts mimicking invasion.

Tips A negative punch biopsy result, where there is definite abnormality on cytology smears or colposcopy, should be followed by further examination & possibly cone biopsy & should not be considered a conclusive investigation.

Technical & Practical Problems in Cervical Biopsies: Endocervical Curettage Sampling problems: - Material not obtained under direct visualization & may not be representative. Interpretation problems: - Fragmentation & poor orientation makes grading difficult.

Tips A negative endocervical curettage result sometimes has uncertain diagnostic reliability. If a significant endocervical glandular lesion is suspected on cytology, cone biopsy provides a more reliable investigation.

Technical & Practical Problems in Cervical Biopsies: Cone Biopsy Interpretation problems: - In laser cones, heat artifact at biopsy edge makes detailed assessment not possible.

Cone Biopsy (Using Laser): Marked Heat Artifact

Cone Biopsy (Using Cold Knife): For Comparison

Technical & Practical Problems in Cervical Biopsies: LLETZ / LEEP Interpretation problems: - Heat artifact can cause nuclear hyperchromasia, apparent nuclear elongation & crowding in glandular mucosa, resulting in misinterpretation as CIN or AIS. - Status of resection margins sometimes difficult to assess due to heat artifact & coagulative necrosis.

LEEP Biopsy: Marked Cauterization Artifact

LEEP Biopsy: Marked Cauterization Artifact

Tips Negative cone / LEEP biopsy can be due to: - False-positive cytology - Regression of lesion - Complete ablation by previous punch biopsy - Insufficient sectioning - Tissue damage (due to heat artifact or loss of surface mucosa) - Failure to excise the lesion (abnormal cytology due to vaginal lesion)